Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. | V.P., Clinical Affairs | Restricted Stock Units | 7.96K | $130K | $16.31 | Mar 15, 2023 | Direct |
Tarsus Pharmaceuticals, Inc. | V.P., Clinical Affairs | Common Stock | 3.19K | $63.8K | $20.00 | Mar 20, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TARS | Tarsus Pharmaceuticals, Inc. | Mar 17, 2023 | 2 | -$4.99K | 4 | Mar 21, 2023 | V.P., Clinical Affairs |
TARS | Tarsus Pharmaceuticals, Inc. | Mar 15, 2023 | 3 | -$2.51K | 4 | Mar 17, 2023 | V.P., Clinical Affairs |
TARS | Tarsus Pharmaceuticals, Inc. | Mar 9, 2022 | 2 | $0 | 4 | Mar 11, 2022 | V.P., Clinical Affairs |